Purification, Molecular Docking and Cytotoxicity Evaluation of Bioactive Pentacyclic Polyhydroxylated Triterpenoids from Salvia urmiensis

Abstract

Triterpenoids, as one of the largest classes of naturally occurring secondary metabolites in higher plants, are of interest due to their high structural diversity and wide range of biological activities. In addition to several promising pharmacological activities such as antimicrobial, antiviral, antioxidant, anti-inflammatory and hepatoprotective effects, a large number of triterpenoids have revealed high potential for cancer therapy through their strong cytotoxicity on cancer cell lines and, also, low toxicity in normal cells. So, this study was aimed at discovering novel and potentially bioactive triterpenoids from the Salvia urmiensis species. For this, an ethyl acetate fraction of the acetone extract of the aerial parts of the plant was chromatographed to yield five novel polyhydroxylated triterpenoids (1–5). Their structure was elucidated by extensive spectroscopic methods including 1D (¹H, ¹³C, DEPT-Q) and 2D NMR (COSY, HSQC, HMBC, NOESY) experiments, as well as HRESIMS analysis. Cytotoxic activity of the purified compounds was also investigated by MTT assay against the MCF-7 cancer cell line. Furthermore, a molecular docking analysis was applied to evaluate the inhibition potential of the ligands against the nuclear factor kappa B (NF-κB) protein, which promotes tumor metastasis or affects gene expression in cancer disease. The 1β,11β,22α-trihydroxy-olean-12-ene-3-one (compound 4) indicated the best activity in both in vitro and in silico assays, with an IC₅₀ value of 32 µM and a docking score value of − 3.976 kcal/mol, respectively.

Keywords

MTT assay - structure elucidation - phytochemical - NMR - Salvia urmiensis - Lamiaceae

Publication History

Received: 02 August 2023

Accepted after revision: 14 January 2024

Accepted Manuscript online:
14 January 2024

Article published online:
18 March 2024

• References

• 1 Ghorbani A, Esmaeilizadeh M. Pharmacological properties of Salvia officinalis and its components. J Tradit Complement Med 2017; 7: 433-440
• 2 Li F, Duan J, Zhao M, Huang S, Mu F, Su J, Liu K, Pan Y, Lu X, Li J. A network pharmacology approach to reveal the protective mechanism of Salvia miltiorrhiza-Dalbergia odorifera coupled-herbs on coronary heart disease. Sci Rep 2019; 9: 19343
• 3 Hussain H, Xiao J, Ali A, Green IR, Westermann B. Unusually cyclized triterpenoids: Occurrence, biosynthesis and chemical synthesis. Nat Prod Rep 2023; 40: 412-451
• 4 Moses T, Papadopoulou KK, Osbourn A. Metabolic and functional diversity of saponins, biosynthetic intermediates and semi-synthetic derivatives. Crit Rev Biochem Mol Biol 2014; 49: 439-462
• 5 Sawai S, Saito K. Triterpenoid biosynthesis and engineering in plants. Front Plant Sci 2011; 2: 25
• 6 Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer 2021; 149: 778-789
• 7 Chaturvedi PK, Bhui K, Shukla Y. Lupeol: connotations for chemoprevention. Cancer Lett 2008; 263: 1-13
• 8 Fulda S. Betulinic acid: A natural product with anticancer activity. Mol Nut Food Res 2009; 53: 140-146
• 9 Ovesna Z, Vachalkova A, Horvathova K, Tothova D. Pentacyclic triterpenoic acids: New chemoprotective compounds Minireview. Neoplasma 2004; 51: 327-333
• 10 Lin CC, Huang CY, Mong MC, Chan CY, Yin MC. Antiangiogenic potential of three triterpenic acids in human liver cancer cells. J Agric Food Chem 2011; 59: 755-762
• 11 Karin M, Greten FR. NF-κB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749-759
• 12 Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006; 4: 221-233
• 13 Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, Pujari VB. Inflammation and cancer. Ann Afr Med 2019; 18: 121
• 14 Farimani MM, Abbas-Mohammadi M, Esmaeili MA, Salehi P, Nejad-Ebrahimi S, Sonboli A, Hamburger M. Seco-ursane-type triterpenoids from Salvia urmiensis with apoptosis-inducing activity. Planta Med 2015; 81: 1290-1295
• 15 Farimani Mm. Bahadori MB, Koulaei SA, Salehi P, Ebrahimi SN, Khavasi HR, Hamburger M. New ursane triterpenoids from Salvia urmiensis Bunge: Absolute configuration and anti-proliferative activity. Fitoterapia 2015; 106: 1-6
• 16 Farimani MM, Abbas-Mohammadi M. Two new polyhydroxylated triterpenoids from Salvia urmiensis and their cytotoxic activity. Nat Prod Res 2016; 30: 2648-2654
• 17 Farimani MM, Nejad Ebrahimi S, Salehi P, Bahadori MB, Sonboli A, Khavasi HR, Zimmermann S, Kaiser M, Hamburger M. Antitrypanosomal triterpenoid with an ε-lactone E-ring from Salvia urmiensis . J Nat Prod 2013; 76: 1806-1809
• 18 Ortega-Muñoz M, Rodríguez-Serrano F, De los Reyes-Berbel E, Mut-Salud N, Hernández-Mateo F, Rodríguez-López A, Garrido JM, López-Jaramillo FJ, Santoyo-González F. Biological evaluation and docking studies of synthetic oleanane-type triterpenoids. ACS Omega 2018; 3: 11455-11468
• 19 Xia L, Tan S, Zhou Y, Lin J, Wang H, Oyang L, Tian Y, Liu L, Su M, Wang H. Role of the NFκB-signaling pathway in cancer. Onco Targets Ther 2018; 11: 2063-2073
• 20 Xia Y, Shen S, Verma IM. NF-κB, an active player in human cancers. Cancer Immunol Res 2014; 2: 823-830
• 21 Ren Y, VanSchoiack A, Chai HB, Goetz M, Kinghorn AD. Cytotoxic barrigenol-like triterpenoids from an extract of Cyrilla racemiflora housed in a repository. J Nat Prod 2015; 78: 2440-2446
• 22 Liu J, Shimizu K, Kondo R. The effects of ganoderma alcohols isolated from Ganoderma lucidum on the androgen receptor binding and the growth of LNCaP cells. Fitoterapia 2010; 81: 1067-1072
• 23 Ren Y, Anaya-Eugenio GD, Czarnecki AA, Ninh TN, Yuan C, Chai HB, Soejarto DD, Burdette JE, de Blanco EJC, Kinghorn AD. Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives. Biorg Med Chem 2018; 26: 4452-4460
• 24 Jäger S, Winkler K, Pfüller U, Scheffler A. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L. Planta Med 2007; 73: 157-162
• 25 Kang HS, Park JE, Lee YJ, Chang IS, Chung YI, Tae G. Preparation of liposomes containing oleanolic acid via micelle-to-vesicle transition. J Nanosci Nanotechnol 2007; 7: 3944-3948
• 26 Strüh C, Jäger S, Schempp C, Scheffler A, Martin S. Solubilized triterpenes from mistletoe show anti-tumor effects on skin-derived cell lines. Planta Med 2008; 74: PD22
• 27 Tao A, Huang Y, Shinohara Y, Caylor ML, Pashikanti S, Xu D. ezCADD: A rapid 2D/3D visualization-enabled web modeling environment for democratizing computer-aided drug design. J Chem Inf Model 2018; 59: 18-24